Ceftaroline fosamil

Chemical formula: C₂₂H₂₁N₈O₈PS₄ Molecular mass: 684.67 g/mol PubChem compound: 9852981

Therapeutic indications

Ceftaroline fosamil is indicated for:

Complicated skin and soft tissue infections (cSSTI)

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Ceftaroline fosamil is indicated for the treatment of complicated skin and soft tissue infections (cSSTI) in neonates, infants, children, adolescents and adults.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

600 mg every 12 hours for 5-14 days

6 to 12 mg/kg every 8 hours or 600 mg every 12 hours based on age group and body weight, for 5-14 days

Community-acquired pneumonia (CAP)

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Ceftaroline fosamil is indicated for the treatment of community-acquired pneumonia (CAP) in neonates, infants, children, adolescents and adults.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

600 mg every 12 hours for 5-7 days

6 to 12 mg/kg every 8 hours or 600 mg every 12 hours based on age group and body weight, for 5-7 days

Contraindications

Ceftaroline fosamil is contraindicated in the following cases:

Lactation

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.